Hester Biosciences has informed that the ‘Trading Window’ for dealing in equity shares of the Company shall remain closed from 1st January 2026 and will end 48 hours after the financial results of the Company for the quarter and nine months period ended 31st December 2025 become generally available as public information.
The above information is a part of company’s filings submitted to BSE.